Literature DB >> 22687345

Risk factors for Parkinson's disease may differ in men and women: an exploratory study.

Rodolfo Savica1, Brandon R Grossardt, James H Bower, J Eric Ahlskog, Walter A Rocca.   

Abstract

Although several environmental and genetic risk or protective factors have been associated with Parkinson's disease (PD), their interactions overall and in men and women separately remain unknown. We used the medical records-linkage system of the Rochester Epidemiology Project to identify 196 subjects who developed PD in Olmsted County, MN, from 1976 through 1995. Each incident case was matched by age (±1 year) and sex to a general population control. We considered the following 12 risk or protective factors: personal history of head trauma, pesticide use, immunologic diseases, anemia, hysterectomy (in women only), cigarette smoking, coffee consumption, and education; and family history of parkinsonism, essential tremor, dementia, or psychiatric disorders. We used recursive partitioning analyses to explore interactions overall and in men and women separately and used logistic regression analyses to test for interactions. In the overall group, we observed the independent effects of anemia, lack of coffee consumption (never vs. ever), and head trauma; however, the findings were different in men and women. In men, we observed the independent effects of lack of coffee consumption (never vs. ever), head trauma, and pesticide use, and a suggestive synergistic interaction between immunologic diseases and family history of dementia. By contrast, in women, anemia was the most important factor and we observed a suggestive synergistic interaction between anemia and higher education. Risk factors for PD and their interactions may differ in men and women.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22687345      PMCID: PMC3477259          DOI: 10.1016/j.yhbeh.2012.05.013

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  59 in total

1.  Use of classification trees for association studies.

Authors:  H Zhang; G Bonney
Journal:  Genet Epidemiol       Date:  2000-12       Impact factor: 2.135

2.  Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.

Authors:  X Gao; D E Dluzen
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

3.  Nonfatal cancer preceding Parkinson's disease: a case-control study.

Authors:  Alexis Elbaz; Brett J Peterson; Ping Yang; Jay A Van Gerpen; James H Bower; Demetrius M Maraganore; Shannon K McDonnell; J Eric Ahlskog; Walter A Rocca
Journal:  Epidemiology       Date:  2002-03       Impact factor: 4.822

4.  Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory.

Authors:  C Leranth; R H Roth; J D Elsworth; F Naftolin; T L Horvath; D E Redmond
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

5.  Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.

Authors:  M D Benedetti; D M Maraganore; J H Bower; S K McDonnell; B J Peterson; J E Ahlskog; D J Schaid; W A Rocca
Journal:  Mov Disord       Date:  2001-09       Impact factor: 10.338

6.  Gender differences in Parkinson's disease symptom profile.

Authors:  B Scott; A Borgman; H Engler; B Johnels; S M Aquilonius
Journal:  Acta Neurol Scand       Date:  2000-07       Impact factor: 3.209

7.  Stereospecific prevention by 17beta-estradiol of MPTP-induced dopamine depletion in mice.

Authors:  S Callier; M Morissette; M Grandbois; T Di Paolo
Journal:  Synapse       Date:  2000-09-15       Impact factor: 2.562

8.  Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study.

Authors:  M Shiba; J H Bower; D M Maraganore; S K McDonnell; B J Peterson; J E Ahlskog; D J Schaid; W A Rocca
Journal:  Mov Disord       Date:  2000-07       Impact factor: 10.338

9.  Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study.

Authors:  M D Benedetti; J H Bower; D M Maraganore; S K McDonnell; B J Peterson; J E Ahlskog; D J Schaid; W A Rocca
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

10.  Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging.

Authors:  M Baldereschi; A Di Carlo; W A Rocca; P Vanni; S Maggi; E Perissinotto; F Grigoletto; L Amaducci; D Inzitari
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

View more
  18 in total

1.  Survival and Progression in Synucleinopathy Phenotypes With Parkinsonism: A Population-Based Study.

Authors:  Rodolfo Savica; Pierpaolo Turcano; James H Bower; J Eric Ahlskog; Michelle M Mielke
Journal:  Mayo Clin Proc       Date:  2019-08-09       Impact factor: 7.616

2.  Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium.

Authors:  Karen Marder; Yuanjia Wang; Roy N Alcalay; Helen Mejia-Santana; Ming-Xin Tang; Annie Lee; Deborah Raymond; Anat Mirelman; Rachel Saunders-Pullman; Lorraine Clark; Laurie Ozelius; Avi Orr-Urtreger; Nir Giladi; Susan Bressman
Journal:  Neurology       Date:  2015-06-10       Impact factor: 9.910

3.  Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Bradley F Boeve; Jonathan Graff-Radford; Walter A Rocca; Michelle M Mielke
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

4.  The complexities of hormonal influences and risk of Parkinson's disease.

Authors:  Connie Marras; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2014-04-30       Impact factor: 10.338

5.  Time Trends in the Incidence of Parkinson Disease.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2016-08-01       Impact factor: 18.302

6.  The future burden of Parkinson's disease.

Authors:  Walter A Rocca
Journal:  Mov Disord       Date:  2017-08-07       Impact factor: 10.338

7.  Infections or Sepsis Preceding Clinically Diagnosed α-Synucleinopathies: A Case-Control Study.

Authors:  Shemonti Hasan; Michelle M Mielke; J Eric Ahlskog; James Bower; Pierpaolo Turcano; Rodolfo Savica
Journal:  Mov Disord       Date:  2020-06-01       Impact factor: 10.338

8.  Incidence of dementia with Lewy bodies and Parkinson disease dementia.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; Bradley F Boeve; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2013-11       Impact factor: 18.302

9.  Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism.

Authors:  Rodolfo Savica; Brandon R Grossardt; James H Bower; J Eric Ahlskog; Walter A Rocca
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

10.  Unsupervised machine learning for the discovery of latent disease clusters and patient subgroups using electronic health records.

Authors:  Yanshan Wang; Yiqing Zhao; Terry M Therneau; Elizabeth J Atkinson; Ahmad P Tafti; Nan Zhang; Shreyasee Amin; Andrew H Limper; Sundeep Khosla; Hongfang Liu
Journal:  J Biomed Inform       Date:  2019-12-28       Impact factor: 6.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.